Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

0
Player Avatar TheBigLab (< 20) Submitted: 7/22/2009 8:25:00 PM : Outperform Start Price: $11.03 ALKS Score: +5.33

Two hit wonder

Featured Broker Partners


Advertisement